Results for makroproteinuri translation from Swedish to English

- etablerad glomerulär diabetesnefropati definierad som makroproteinuri hos patienter med minst en
the mah proposed indication “ secondary prevention after mi in patients with heart failure” has been justified on the basis of the:

manifest glomerulär icke- diabetisk nefropati definierad av makroproteinuri ≥ 3g/ dag
manifest glomerular non-diabetic nephropathy as defined by macroproteinuria ≥ 3g/ day

manifest glomerulär diabetisk nefropati fastställd genom makroproteinuri hos patienter med minst en kardiovaskulär riskfaktor
manifest glomerular diabetic nephropathy as defined by macroproteinuria in patients with at least one cardiovascular risk factor

och slutligen, när det gäller patienter med nefropati utan diabetes, men med makroproteinuri ≥ 3 g/ dag, är rekommenderad begynnelsedos 1, 25 mg tritace en gång dagligen.
and finally, for patients with non diabetic nephropathy macroproteinuria ≥ 3gm/ day, the recommended initial dose is 1.25 mg of tritace once daily.

behandling av njursjukdom • begynnande glomerulär diabetisk nefropati fastställd genom förekomst av mikroalbuminuri • manifest glomerulär diabetisk nefropati fastställd genom makroproteinuri hos patienter med minst en kardiovaskulär riskfaktor • manifest glomerulär icke- diabetisk nefropati definierad av makroproteinuri ≥ 3g/ dag
treatment of renal disease • incipient glomerular diabetic nephropathy as defined by the presence of microalbuminuria • manifest glomerular diabetic nephropathy as defined by macroproteinuria in patients with at least one cardiovascular risk factor • manifest glomerular non-diabetic nephropathy as defined by macroproteinuria ≥ 3g/ day